Skip to results
Modify your search
NARROW
1-20 of 62
Authors: Maya H Buch
Journal Article
P063 Health literacy and disease, clinical, functional and management outcomes in inflammatory arthritis: a systematic literature review
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.105, https://doi.org/10.1093/rheumatology/keaf142.105
Published: 28 April 2025
Journal Article
OA38 Prevalence of cardiovascular disease and its risk factors in rare autoimmune rheumatic diseases: results from a large population-based study
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.038, https://doi.org/10.1093/rheumatology/keaf142.038
Published: 28 April 2025
Journal Article
Baseline synovitis–tenosynovitis is associated with remission in early rheumatoid arthritis, but discordance with disease activity is a changeable state
Rheumatology, keaf098, https://doi.org/10.1093/rheumatology/keaf098
Published: 17 February 2025
Journal Article
Foot peripheral sensory neuropathy: a frequent disabling manifestation in systemic sclerosis
Rheumatology, keaf047, https://doi.org/10.1093/rheumatology/keaf047
Published: 29 January 2025
Journal Article
Initial survey of UK rheumatologists to inform a national cardio-rheumatology strategy Get access
Rheumatology, Volume 64, Issue 3, March 2025, Pages 1541–1542, https://doi.org/10.1093/rheumatology/keae567
Published: 16 October 2024
Journal Article
Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate
Rheumatology, Volume 64, Issue 4, April 2025, Pages 1661–1671, https://doi.org/10.1093/rheumatology/keae486
Published: 27 September 2024
Journal Article
EDITOR'S CHOICE
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis
Rheumatology, Volume 63, Issue 11, November 2024, Pages 2956–2975, https://doi.org/10.1093/rheumatology/keae394
Published: 11 September 2024
Journal Article
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis—executive summary
Rheumatology, Volume 63, Issue 11, November 2024, Pages 2948–2955, https://doi.org/10.1093/rheumatology/keae390
Published: 11 September 2024
Journal Article
P143 High throughput multiplex assay identifies clinically meaningful clusters in systemic sclerosis patients with low cardiovascular risk and no history of heart disease
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.182, https://doi.org/10.1093/rheumatology/keae163.182
Published: 24 April 2024
Journal Article
P117 Efficacy of filgotinib in patients with rheumatoid arthritis: Week 156 results from a long-term extension study
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.158, https://doi.org/10.1093/rheumatology/keae163.158
Published: 24 April 2024
Journal Article
P126 Use of oral contraceptives in females with rheumatoid arthritis is not associated with an increased risk of venous thromboembolism: United Kingdom-population based study
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.167, https://doi.org/10.1093/rheumatology/keae163.167
Published: 24 April 2024
Journal Article
OA27 Molecular divergences in CD4+ T Cells between early and refractory rheumatoid arthritis
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.027, https://doi.org/10.1093/rheumatology/keae163.027
Published: 24 April 2024
Journal Article
P052 Rheumatoid arthritis associated risk of venous thromboembolism is not dependent on disease duration: United Kingdom-based population study
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.094, https://doi.org/10.1093/rheumatology/keae163.094
Published: 24 April 2024
Journal Article
OA02 Longitudinal high throughput proteomics identifies novel proteins associated with inflammation and future response in new-onset, treatment-naïve rheumatoid arthritis
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.002, https://doi.org/10.1093/rheumatology/keae163.002
Published: 24 April 2024
Journal Article
OA38 Venous thromboembolism risk is consistently increased in people with rheumatoid arthritis across different ages, sexes and obesity status: United Kingdom population-based study
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.038, https://doi.org/10.1093/rheumatology/keae163.038
Published: 24 April 2024
Journal Article
E061 Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: a survey of UK-based rheumatologists
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.288, https://doi.org/10.1093/rheumatology/keae163.288
Published: 24 April 2024
Journal Article
OA06 Clinical outcomes of filgotinib in patients with rheumatoid arthritis aged ≥65 years: a post hoc subgroup analysis of Phase 2 and 3 clinical trials and ongoing long-term extensions
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.006, https://doi.org/10.1093/rheumatology/kead104.006
Published: 24 April 2023
Journal Article
P111 Exploratory Analysis of Filgotinib Safety Data in Patients With Moderately to Severely Active Rheumatoid arthritis and an Increased Risk of Cardiovascular Events: Data From Phase 2 and 3 Clinical Trials
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.152, https://doi.org/10.1093/rheumatology/kead104.152
Published: 24 April 2023
Journal Article
P037 The NIHR IMID Bioresource: a descriptive analysis of the first 5000 participants
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.078, https://doi.org/10.1093/rheumatology/kead104.078
Published: 24 April 2023
Journal Article
P137 First-line tumour necrosis factor inhibitor (TNFi) treatment is associated with high multi-criteria remission early on compared to treat-to-target in a treatment naïve RA cohort
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.178, https://doi.org/10.1093/rheumatology/kead104.178
Published: 24 April 2023
